Rattus norvegicus (rat): 25402
Help
Entry
25402 CDS
T01003
Symbol
Casp3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
rno
Rattus norvegicus (rat)
Pathway
rno01524
Platinum drug resistance
rno04010
MAPK signaling pathway
rno04115
p53 signaling pathway
rno04148
Efferocytosis
rno04210
Apoptosis
rno04215
Apoptosis - multiple species
rno04623
Cytosolic DNA-sensing pathway
rno04650
Natural killer cell mediated cytotoxicity
rno04657
IL-17 signaling pathway
rno04668
TNF signaling pathway
rno04726
Serotonergic synapse
rno04932
Non-alcoholic fatty liver disease
rno04933
AGE-RAGE signaling pathway in diabetic complications
rno04936
Alcoholic liver disease
rno05010
Alzheimer disease
rno05012
Parkinson disease
rno05014
Amyotrophic lateral sclerosis
rno05016
Huntington disease
rno05020
Prion disease
rno05022
Pathways of neurodegeneration - multiple diseases
rno05132
Salmonella infection
rno05133
Pertussis
rno05134
Legionellosis
rno05145
Toxoplasmosis
rno05146
Amoebiasis
rno05152
Tuberculosis
rno05160
Hepatitis C
rno05161
Hepatitis B
rno05162
Measles
rno05163
Human cytomegalovirus infection
rno05164
Influenza A
rno05165
Human papillomavirus infection
rno05167
Kaposi sarcoma-associated herpesvirus infection
rno05168
Herpes simplex virus 1 infection
rno05169
Epstein-Barr virus infection
rno05170
Human immunodeficiency virus 1 infection
rno05200
Pathways in cancer
rno05203
Viral carcinogenesis
rno05205
Proteoglycans in cancer
rno05206
MicroRNAs in cancer
rno05210
Colorectal cancer
rno05222
Small cell lung cancer
rno05416
Viral myocarditis
rno05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
rno00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
25402 (Casp3)
04668 TNF signaling pathway
25402 (Casp3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
25402 (Casp3)
09143 Cell growth and death
04210 Apoptosis
25402 (Casp3)
04215 Apoptosis - multiple species
25402 (Casp3)
04115 p53 signaling pathway
25402 (Casp3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
25402 (Casp3)
04650 Natural killer cell mediated cytotoxicity
25402 (Casp3)
04657 IL-17 signaling pathway
25402 (Casp3)
09156 Nervous system
04726 Serotonergic synapse
25402 (Casp3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
25402 (Casp3)
05206 MicroRNAs in cancer
25402 (Casp3)
05205 Proteoglycans in cancer
25402 (Casp3)
05203 Viral carcinogenesis
25402 (Casp3)
09162 Cancer: specific types
05210 Colorectal cancer
25402 (Casp3)
05222 Small cell lung cancer
25402 (Casp3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
25402 (Casp3)
05161 Hepatitis B
25402 (Casp3)
05160 Hepatitis C
25402 (Casp3)
05164 Influenza A
25402 (Casp3)
05162 Measles
25402 (Casp3)
05168 Herpes simplex virus 1 infection
25402 (Casp3)
05163 Human cytomegalovirus infection
25402 (Casp3)
05167 Kaposi sarcoma-associated herpesvirus infection
25402 (Casp3)
05169 Epstein-Barr virus infection
25402 (Casp3)
05165 Human papillomavirus infection
25402 (Casp3)
09171 Infectious disease: bacterial
05132 Salmonella infection
25402 (Casp3)
05133 Pertussis
25402 (Casp3)
05134 Legionellosis
25402 (Casp3)
05152 Tuberculosis
25402 (Casp3)
09174 Infectious disease: parasitic
05146 Amoebiasis
25402 (Casp3)
05145 Toxoplasmosis
25402 (Casp3)
09164 Neurodegenerative disease
05010 Alzheimer disease
25402 (Casp3)
05012 Parkinson disease
25402 (Casp3)
05014 Amyotrophic lateral sclerosis
25402 (Casp3)
05016 Huntington disease
25402 (Casp3)
05020 Prion disease
25402 (Casp3)
05022 Pathways of neurodegeneration - multiple diseases
25402 (Casp3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
25402 (Casp3)
05416 Viral myocarditis
25402 (Casp3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
25402 (Casp3)
04932 Non-alcoholic fatty liver disease
25402 (Casp3)
04933 AGE-RAGE signaling pathway in diabetic complications
25402 (Casp3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
25402 (Casp3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
rno01002
]
25402 (Casp3)
Enzymes [BR:
rno01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
25402 (Casp3)
Peptidases and inhibitors [BR:
rno01002
]
Cysteine peptidases
Family C14: caspase family
25402 (Casp3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
aRib
Glycos_trans_3N
Motif
Other DBs
NCBI-GeneID:
25402
NCBI-ProteinID:
NP_037054
RGD:
2275
Ensembl:
ENSRNOG00000010475
UniProt:
P55213
A6JPM9
LinkDB
All DBs
Position
16:complement(45662910..45681171)
Genome browser
AA seq
277 aa
AA seq
DB search
MDNNETSVDSKSINNFETKTIHGSKSMDSGIYLDSSYKMDYPEMGLCIIINNKNFHKSTG
MSARNGTDVDAANLRETFMALKYEVRNKNDLTREEIMELMDSVSKEDHSKRSSFVCVILS
HGDEGVIFGTNGPVDLKKLTSFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGTDD
DMACQKIPVEADFLYAYSTAPGYYSWRNSRDGSWFIQSLCAMLKLYAHKLEFMHILTRVN
RKVATEFESFSLDATFHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggacaacaacgaaacctccgtggattcaaaatccattaataattttgaaacaaagact
atccatggaagcaagtcgatggactctggaatatatctggacagcagttacaaaatggat
taccctgaaatgggcttgtgtataataattaataataagaacttccataaaagcactgga
atgtcagctcgcaatggtaccgatgtcgatgcagctaacctcagagagacattcatggcc
ctgaaatacgaagtcaggaataaaaatgaccttactcgtgaagaaattatggaattgatg
gatagtgtttctaaggaagatcacagcaaaaggagcagttttgtgtgtgtgattctaagt
catggagatgaaggagtaatttttggaacgaacggacctgtggacctgaaaaaactaact
agtttcttcagaggcgactactgccggagtctgactggaaagccgaaactcttcatcatt
caggcctgccgaggtacagagctggactgcggtattgagacagacagtggaactgacgat
gatatggcatgccagaagataccagtggaggccgacttcctgtatgcttactctaccgca
cccggttactattcctggagaaattcaagggacgggtcatggttcatccagtcactttgc
gccatgctgaaactgtacgcgcacaagctggaattcatgcacatcctcactcgtgttaac
cggaaggtggccacggaatttgagtccttctccctggacgccactttccatgcaaagaaa
cagatcccgtgtattgtgtcaatgctcacaaaagaactgtacttttatcactaa
DBGET
integrated database retrieval system